Q1 2017

Filed Jul 14, 2017 · 10-Q · 44 days after period end · 0001193805-17-001292

Q1 2017 · 10-Q

Revenue

$0.00

— vs Q1 2016

Net Income

-$43.00K

N/M vs Q1 2016

EPS Diluted

-$0.04

N/M vs Q1 2016

Operating Income-$23,000N/M

Operating Cash Flow

Same quarter

Metric	Q1 2017	Q1 2016	Q1 2015	Q1 2014
Revenue	$0.00	$0.00	$0.00	$0.00
Net Income	-$43.00K	-$34.00K	-$31.00K	-$29.00K
EPS Diluted	-$0.04	-$0.03	-$0.03	-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR